Curaleaf Holdings, Inc. (CURLF)
2.36
+0.06
(+2.61%)
USD |
OTCM |
Mar 13, 16:00
Curaleaf Holdings EPS Diluted (Quarterly) : -0.0905 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.37M |
| Revenue (Quarterly) | 333.07M |
| Total Expenses (Quarterly) | 394.64M |
| Enterprise Value | 2.848B |
| Gross Profit Margin (Quarterly) | 37.95% |
| Profit Margin (Quarterly) | -17.82% |
| Earnings Yield | -13.44% |
| Operating Earnings Yield | 1.01% |
| Normalized Earnings Yield | -13.16 |